… in the scientific journal Neurology sheds new light on how diabetes affects Parkinson's disease risk. While the … between the two diseases was known, this study adds to our understanding of who is most at risk. Researchers at … rose to 49 percent greater risk for people experiencing complications from their diabetes and 400 percent for …

… striatum undergo maladaptive biochemical changes leading to their hyperactivation under conditions of levodopa … (LID).  We propose here an approach to precisely target hyperactive ChIs through a non-cholinergic receptor … that are enriched in ChIs has been identified by their comparison with the transcript profiles from 140 additional …

… UPDATE September 13, 2018: Acorda Therapeutics, Inc today announced that the U.S. Food and Drug Administration … is known about inhaled levodopa -- clinical trial data, how the drug works and how it's made. This review process is … medication isn't working well. These "off" times can come on gradually, before it's time to take the next …

… abnormal proteins—α-synuclein, tau, and TDP-43—that clump together in brain cells. These protein clumps don't act … or exposure to environmental toxins, specialized cellular compartments called stress granules become rigid and trap … proteins, thereby exacerbating the disease. Understanding how these proteins interact during stress could reveal new …

… PPMI investigator Victor Sung, MD, with Jean Burns Jean Burns was … friend Sheryl Jedlinksi. Jean is a member of the Patient Committee of the Parkinson’s Progression Markers Initiative … It just makes me want to participate in more studies to see how I can help.   I’d like to close with a huge thank you to …

… of Parkinson's disease relies on expert opinion. Autopsy studies, however, have demonstrated that even experienced … glass slide, known as microarray. We hypothesize that a comparison of the gene chip analyses of blood samples from …